Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Financial Results For Quarter And Nine Months Ended On December 31, 2021

 In accordance with the provisions of Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations 2015'), we wish to inform that the Board of Directors of JHS Svendgaard Laboratories Limited ('the Company') at their meeting held today i.e on Tuesday, 08th February 2022 has, inter alia, transacted the following businesses: 1. Approved the Un-audited Financial Results (Standalone and Consolidated) (UFRs) of the Company for the quarter and nine months'' period ended on 31st December, 2021 pursuant to Regulation 33 of Listing Regulations 2015 (enclosed herewith as Annexure-A). 2. Taken on record the Limited Review Report of M/s S. N. Dhawan & Co., Chartered Accountants (Statutory Auditor) on the above UFRs (enclosed herewith as Annexure-A).
08-02-2022
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Board Meeting Outcome for Outcome Of Board Meeting

 1. Approved the Un-audited Financial Results (Standalone and Consolidated) (UFRs) of the Company for the quarter and nine months'' period ended on 31st December, 2021 pursuant to Regulation 33 of Listing Regulations 2015 2. Taken on record the Limited Review Report of M/s S. N. Dhawan & Co., Chartered Accountants. w.e.f. 08th February 2022. 4. Allotted of 5,00,000 (Five Lakh) Equity Shares of face value of Rs, 10/- each pursuant to conversion of 5,00,000 Fully Convertible Warrants ('Warrants'), issued as on September 22, 2020 at an issue price of Rs, 20/- each, by way of preferential allotment on a private placement basis, to Mr. Nikhil Nanda, Managing Director and Promoter of the Company.
08-02-2022
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Board Meeting Intimation for Quarterly Results

 JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 ,inter alia, to consider and approve 1. the Un-Audited financial result (Standalone & Consolidated) of the Company for the 3rd quarter ended on 31st December 2021; 2. To take on record the Limited Review Report from the Statutory Auditors M/s. S.N. Dhawan & Co. LLP for the 3rd quarter ended on 31st December 2021. 3. Appointment of Mr. Avinash Pratap as Company Secretary & Compliance Officer of the Company.
31-01-2022
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Shareholding for the Period Ended December 31, 2021

 JHS Svendgaard Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
21-01-2022
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2021.
18-01-2022
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashish GoelDesignation :- Chief Financial Officer
14-01-2022
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Closure of Trading Window

 This is to inform you that in terms of the provisions of sub-regulation (1) of Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015 read along with Company's 'Code of Conduct for Prevention of Insider Trading' read with 'Code of Conduct for Practices and Procedures Fair Disclosure of Unpublished Price Sensitive Information (UPSI)', the Trading Window for dealing in the securities of the Company will remain closed for all insiders including designated persons and their immediate relatives is closed from Saturday, January 01, 2022 till 48 hours after the announcement of Financial Results for the 3rd Quarter ending on December 31, 2021 ('results') for the financial year 2021-2022 to the Stock Exchanges. The details of the date of the Board meeting, in which the said results will be considered, shall be intimated in due course. The above information is also available on the website of the Company i.e. www.svendgaard.com.
30-12-2021
Bigul

JHS Svendgaard Laboratories Ltd - 532771 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Please find enclosed a presentation on the Un-Audited Financial Results of JHS Svendgaard Laboratories Limited for the quarter and half year ended on 30 September, 2021.
03-11-2021
Bigul

JHS Svendgaard Laboratories Ltd - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 We hereby enclose copies of newspapers publications in which extract of Unaudited Financial Results (Standalone and Consolidated) for the Second Quarter & Half year ended 30 September, 2021 are published on 03 November, 2021 in Mint (English) and Business Standard (Hindi).
03-11-2021

JHS Svendgaard Standalone September 2021 Net Sales at Rs 23.06 crore, down 24.03% Y-o-Y

 NULL
03-11-2021
Next Page
Close

Let's Open Free Demat Account